Pulmatrix, Inc. (PULM)
NASDAQ: PULM · Real-Time Price · USD
1.500
-0.040 (-2.60%)
At close: Jun 23, 2026, 4:00 PM EDT
1.460
-0.040 (-2.67%)
After-hours: Jun 23, 2026, 6:15 PM EDT
Pulmatrix Market Cap
Pulmatrix has a market cap or net worth of $5.48 million as of June 23, 2026. Its market cap has decreased by -83.13% in one year.
Market Cap
5.48M
Enterprise Value
2.12M
1-Year Change
-83.13%
Ranking
Category
Stock Price
$1.50
Market Cap Chart
Since June 16, 2015, Pulmatrix's market cap has decreased from $165.85M to $5.48M, a decrease of -96.70%. That is a compound annual growth rate of -26.60%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jun 23, 2026 | 5.48M | -32.74% |
| Dec 31, 2025 | 8.14M | -68.05% |
| Dec 31, 2024 | 25.49M | 275.27% |
| Dec 29, 2023 | 6.79M | -51.89% |
| Dec 30, 2022 | 14.12M | -42.64% |
| Dec 31, 2021 | 24.61M | -39.88% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| PMGC Holdings | 6.13M |
| BioAtla | 6.00M |
| Aptevo Therapeutics | 5.92M |
| Cardio Diagnostics Holdings | 5.83M |
| Genprex | 5.82M |
| Adial Pharmaceuticals | 5.81M |
| Soligenix | 5.78M |
| XTL Biopharmaceuticals | 5.72M |